Oncology Central

MAGIC trial infographic – APF530 in three-drug regimen for CINV


Following the publication of the results of the Phase III MAGIC trial in Future Oncologyavailable here – we’ve summarized some of the key trial data in the infographic below. Scroll down to learn more about the efficacy of APF530 for the treatment of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.